Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Costs and benefits of diagnosing familial breast cancer.

Disease markers - 1 Oct 1999

Heimdal K, Maehle L, Møller P

Abstract excerpt

Based on results from our surveillance program for women at risk for inherited breast cancer, we have calculated cost per year earned. Norwegian National Insurance Service reimbursement fees were used in the calculations. The calculated costs are based on empirical figures for expanding already established medical genetic departments and diagnostic outpatient clinics to undertake the work described. Cost per year...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Laboratories
Share to Life Expectancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mammography

Share to Mastectomy

Share to National Health Programs

Share to Ovariectomy

Share to Prejudice

Source

Open in PubMed Open full text

Identifiers

PMID: 10595273
DOI: 10.1155/1999/751892
PMCID: PMC3851967

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Costs and benefits of diagnosing familial breast cancer.PMID 10595273Read ↗

Evaluation of a surveillance programme for women with a family history of breast cancer.Semantic proximity Read ↗

Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio.Semantic proximity Read ↗

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.Semantic proximity Read ↗

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read ↗

Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis.Semantic proximity Read ↗

Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.Semantic proximity Read ↗

The challenge of evaluating annual mammography screening for young women with a family history of breast cancer.Semantic proximity Read ↗

Health economics and genetic service development: a familial cancer genetic example.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.